Spray-dried chitosan as a direct compression tableting excipient

Drug Development and Industrial Pharmacy

Volumn 35, Issue 1, 2009, Pages 43-48

  Chinta, Dakshinamurthy Devanga ^a   Graves, Richard A ^a   Pamujula, Sarala ^a   Praetorius, Natalie ^a   Bostanian, Levon A ^a   Mandal, Tarun K ^a  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

Chitosan; Direct compression; Granulation; Spray drying; Tablets

Indexed keywords

BICARBONATE; CHITOSAN; EXCIPIENT; LACTOSE; PROPRANOLOL;

AQUEOUS SOLUTION; ARTICLE; BULK DENSITY; DRUG RELEASE; FLOW; MOLECULAR WEIGHT; PARTICLE SIZE; SPRAY DRYING; TABLET COMPRESSION;

CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CITRIC ACID; EXCIPIENTS; LACTOSE; MOLECULAR WEIGHT; PARTICLE SIZE; PROPRANOLOL; SODIUM BICARBONATE; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 56749156397     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802149053     Document Type: Article

References (29)

1. Agnihotri, S. A., & Aminabhavi, T. M. (2007). Chitosan nanogranules for prolonged delivery of timolol maleate. Drug Dev. Ind. Pharm., 33, 1254-1262.
2. Aspden, T. J., Adler, J., Davis, S. S., Skaugrud, O., & Illum, L. (1995). Chitosan as a nasal delivery system: Evaluation of the effect of chitosan on mucociliary clearance rate in the frog palate model. Int. J. Pharm., 122, 69-78.
3. Aspden, T. J., Manson, J. D. T., Jones, N., Lowe, J., Skaugrud, O., & Illum, L. (1997). Chitosan as a nasal delivery system: The effect of chitosan on in vitro and in vivo mucociliary transport rates. J. Pharm. Sci., 86, 509-513.
4. Aspden, T., Illum, L., & Skaugrud, O. (1996). Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci., 4, 23-31.
5. Aspden, T., Illum, L., & Skaugrud, O. (1997). The effect of chronic nasal application of chitosan solution on cilia beat frequency in Guinea pigs. Int. J. Pharm., 153, 137-146.
6. Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997). Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm., 153, 41-50.
7. Corrigan, D. O., Healy, A. M., & Corrigan, O. I. (2002). The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties. Int. J. Pharm., 235, 193-205.
8. Felt, O., Buri, P., & Gurny, R. (1998). Chitosan: A unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm., 24, 979-993.
9. Gerber, J. J., & Lotter, A. P. (1993). Compatibility study between propranolol hydrochloride and tablet excipients using differential scanning calorimetry. Drug Dev. Ind. Pharm., 19(5), 623-629.
10. He, P., Davis, S. S., & Illum, L. (1999). Chitosan microspheres prepared by spray drying. Int. J. Pharm., 187, 53-65.
11. Illum, L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm. Res., 15, 1326-1331.
12. Karlsen, J. (1991). Excipient properties of chitosan. Manuf. Chem., 62, 18-19.
13. Knapczyk, J. (1993). Excipient ability of chitosan for direct tableting. Int. J. Pharm., 89, 1-7.
14. Kokil, S., Patil, P., Mahadik, K., & Paradkar, A. (2005). Studies on spray-dried mixtures of chitosan and hydrolyzed gelatin as tablet binder: A technical note. AAPS PharmSciTech., 6, E437- E443.
15. Kotze, A. F., De Leeuw, B. J., LueBen, H. L., De Boer, A. G., Verhoef, J. C., & Juginger, H. E. (1997). Chitosan for enhanced delivery of therapeutic peptides across intestinal epithelia: In vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm., 159, 243-253.
16. LeHoux, J. G., & Grondin, F. (1993). Some effects of chitosan on liver function in the rat. Endocrinology, 132, 1078-1084.
17. Mladenovska, K., Cruaud, O., Richomme, P., Belamie, E., Raicki, R. S., Venier-Julienne, M.-C., Popovski, E., & Goracinova, K.(2007). 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization. Int. J. Pharm., 345, 59-69.
18. Nunthanid, J., Laungtana-anan, M., Sriamornsak, P., Limmatvapirat, S., Puttipipatkhachorn, S., Lim, L. Y., & Khor, E. (2004). Characterization of chitosan acetate as a binder for sustained release tablets. J. Control. Release, 99, 15-26.
19. Ormrod, D. J., Holmes, C. C., & Miller, T. E. (1998). Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis, 138, 329-334.
20. Rege, P. R., Garmis, R. J., & Block, L. H. (2003). Spray-dried chitinosans. Part II: In vitro drug release from tablets made from spray-dried chitinosans. Int. J. Pharm., 252, 53-59.
21. Ritthidej, G. C., Chomto, P., Pummangura, S., & Menasveta, P. (1994). Chitin and chitosan as disintegrants in paracetamol tablets. Drug Dev. Ind. Pharm., 20, 2109-2134.
22. Sawayanagi, Y., Nambu, N., & Nagai, T. (1982a). Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch. Chem. Pharm. Bull., 30, 2935-2940.
23. Sawayanagi, Y., Nambu, N., & Nagai, T. (1982b). Directly compressed tablets containing chitin or chitosan in addition to mannitol. Chem. Pharm. Bull., 30, 4216-4218.
24. Sezer, A. D., & Akbuga, J. (1995). Controlled release of piroxicam from chitosan beads. Int. J. Pharm., 121, 113-116.
25. Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T., & Kawashima, Y. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan coated liposomes. Pharm. Res., 13, 896-901.
26. Takeuchi, H., Yasuji, T., Yamamoto, H., & Kawashima, Y. (1999). Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm. Res., 17, 94-99.
27. Tarimci, N., & Ermis, D. (1997). Sustained release characteristics and pharmacokinetic parameters of ketoprofen suppositories using chitosan. Int. J. Pharm., 147, 71-77.
28. Upadrashta, S. M., Katikaneni, P. R., & Nuessle, N. O. (1992). Chitosan as a tablet binder. Drug Dev. Ind. Pharm., 18, 2701-2708.
29. Wells, J. (2002). Pharmaceutical preformulation: The physicochemical properties of drug substances In M. E. Aulton (Ed.), Pharmaceutics: The science of dosage form design (pp. 133-134). New York: Churchill Livingstone.